Goldman Sachs’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Sell |
109,379
-65,841
| -38% | -$938K | ﹤0.01% | 3572 |
|
|
2025
Q1 | $2.27M | Buy |
175,220
+45,341
| +35% | +$589K | ﹤0.01% | 3277 |
|
|
2024
Q4 | $1.73M | Buy |
+129,879
| New | +$1.73M | ﹤0.01% | 3575 |
|
|
2024
Q3 | – | Sell |
-57,503
| Closed | -$189K | – | 4884 |
|
|
2024
Q2 | $189K | Sell |
57,503
-61,352
| -52% | -$202K | ﹤0.01% | 4386 |
|
|
2024
Q1 | $446K | Buy |
+118,855
| New | +$446K | ﹤0.01% | 4042 |
|
|
2023
Q4 | – | Sell |
-25,650
| Closed | -$107K | – | 4809 |
|
|
2023
Q3 | $107K | Buy |
+25,650
| New | +$107K | ﹤0.01% | 4377 |
|
|
2022
Q2 | – | Sell |
-17,610
| Closed | -$77K | – | 5735 |
|
|
2022
Q1 | $77K | Buy |
+17,610
| New | +$77K | ﹤0.01% | 5378 |
|
|
2021
Q4 | – | Sell |
-20,446
| Closed | -$103K | – | 5563 |
|
|
2021
Q3 | $103K | Buy |
+20,446
| New | +$103K | ﹤0.01% | 5046 |
|